Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/65281
Type
ArticleCopyright
Restricted access
Collections
- IOC - Artigos de Periódicos [12982]
Metadata
Show full item record
ASSOCIATION OF MICA AND HLA-B ALLELES WITH LEPROSY IN TWO ENDEMIC POPULATIONS IN BRAZIL
Author
Jarduli, Luciana Ribeiro
Alves, Hugo Vicentin
Souza, Victor Hugo de
Sartori, Priscila Verchai Uaska
Fava, Vinícius Medeiros
Souza, Fabiana Covolo de
Marcos, Elaine Valim Camarinha
Pereira, Ana Carla
Baptista, Ida Maria Foschiani Dias
Virmond, Marcos da Cunha Lopes
Moraes, Milton Ozório
Mira, Marcelo Távora
Visentainer, Jeane Eliete Laguila
Alves, Hugo Vicentin
Souza, Victor Hugo de
Sartori, Priscila Verchai Uaska
Fava, Vinícius Medeiros
Souza, Fabiana Covolo de
Marcos, Elaine Valim Camarinha
Pereira, Ana Carla
Baptista, Ida Maria Foschiani Dias
Virmond, Marcos da Cunha Lopes
Moraes, Milton Ozório
Mira, Marcelo Távora
Visentainer, Jeane Eliete Laguila
Affilliation
State University of Maringá. Department of Clinical Analysis and Biomedicine. Graduate Program in Biosciences and Physiopathology. Maringá, PR, Brazil.
State University of Maringá. Department of Clinical Analysis and Biomedicine. Graduate Program in Biosciences and Physiopathology. Maringá, PR, Brazil.
State University of Maringá. Department of Clinical Analysis and Biomedicine. Graduate Program in Biosciences and Physiopathology. Maringá, PR, Brazil.
Pontifícia Universidade Católica do Paraná. School of Medicine. Graduate Program in Health Sciences. Curitiba, PR, Brazil.
McGill University Health Centre. Research Institute. Infectious Diseases and Immunity in Global Health Program. Montreal, QC, Canada.
Lauro de Souza Lima Institute. Bauru, SP, Brazil.
Lauro de Souza Lima Institute. Bauru, SP, Brazil.
Lauro de Souza Lima Institute. Bauru, SP, Brazil.
Lauro de Souza Lima Institute. Bauru, SP, Brazil.
Lauro de Souza Lima Institute. Bauru, SP, Brazil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Pontifícia Universidade Católica do Paraná. School of Medicine. Graduate Program in Health Sciences. Curitiba, PR, Brazil.
Pontifícia Universidade Católica do Paraná. School of Medicine. Graduate Program in Health Sciences. Curitiba, PR, Brazil / State University of Maringá. Department of Basic Health Sciences. Maringá, PR, Brazil.
State University of Maringá. Department of Clinical Analysis and Biomedicine. Graduate Program in Biosciences and Physiopathology. Maringá, PR, Brazil.
State University of Maringá. Department of Clinical Analysis and Biomedicine. Graduate Program in Biosciences and Physiopathology. Maringá, PR, Brazil.
Pontifícia Universidade Católica do Paraná. School of Medicine. Graduate Program in Health Sciences. Curitiba, PR, Brazil.
McGill University Health Centre. Research Institute. Infectious Diseases and Immunity in Global Health Program. Montreal, QC, Canada.
Lauro de Souza Lima Institute. Bauru, SP, Brazil.
Lauro de Souza Lima Institute. Bauru, SP, Brazil.
Lauro de Souza Lima Institute. Bauru, SP, Brazil.
Lauro de Souza Lima Institute. Bauru, SP, Brazil.
Lauro de Souza Lima Institute. Bauru, SP, Brazil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Pontifícia Universidade Católica do Paraná. School of Medicine. Graduate Program in Health Sciences. Curitiba, PR, Brazil.
Pontifícia Universidade Católica do Paraná. School of Medicine. Graduate Program in Health Sciences. Curitiba, PR, Brazil / State University of Maringá. Department of Basic Health Sciences. Maringá, PR, Brazil.
Abstract
Leprosy is a prevalent disease in Brazil, which ranks as the country with the second highest number of cases in the world. The disease manifests in a spectrum of forms, and genetic differences in the host can help to elucidate the immunopathogenesis. For a better understanding of MICA association with leprosy, we performed a case–control and a family-based study in two endemic populations in Brazil. MICA and HLA-B alleles were evaluated in 409 leprosy patients and in 419 healthy contacts by PCR-SSOP-Luminex-based technology. In the familial study, analysis of 46 families was completed by direct sequencing of all exons and 3′/5′untranslated regions, using the Ilumina MiSeq platform. All data were collected between 2006 and 2009. Statistical analysis was performed using the Chi-square or Fisher's exact test together with a multivariate analysis. Family-based association was assessed by transmission disequilibrium test (TDT) software FBAT 2.0.4. We found associations between the haplotype MICA*002-HLA-B*35 with leprosy in both the per se and the multibacillary (MB) forms when compared to healthy contacts. The MICA allele *008 was associated with the clinical forms of paucibacillary (PB). Additionally, MICA*029 was associated with the clinical forms of MB. The association of MICA*029 allele (MICA-A4 variant) with the susceptibility to the MB form suggests this variant for the transmembrane domain of the MICA molecule may be a risk factor for leprosy. Two MICA and nine HLA-B variants were found associated with leprosy per se in the Colônia do Prata population. Linkage disequilibrium analysis revealed perfect linkage disequilibrium (LD) between HLA-B markers rs2596498 and rs2507992, and high LD (R² = .92) between these and the marker rs2442718. This familial study demonstrates that MICA association signals are not independent from those observed for HLA-B. Our findings contribute the knowledge pool of the immunogenetics of Hansen's disease and reveals a new association of the MICA*029 allele.
Share